Moexa Pharmaceuticals
Founded Year
2014About Moexa Pharmaceuticals
Moexa Pharmaceuticals is a multi-national drug research and development company engaging in proprietary Smad3 signaling technology. The company has developed anti-tumor therapeutics that address unmet medical needs in cancer immunotherapy, and in fibrotic disease, with solid patents in place protecting IP. The company is expanding its pipeline and advancing towards FDA IND approvals and has active interest from major pharma partners pending the conclusion of IND approval.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Moexa Pharmaceuticals Patents
Moexa Pharmaceuticals has filed 1 patent.
The 3 most popular patent topics include:
- Clusters of differentiation
- Experimental cancer drugs
- Oncology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/6/2019 | Oncology, Experimental cancer drugs, Clusters of differentiation, Transcription factors, Proteins | Application |
Application Date | 8/6/2019 |
|---|---|
Grant Date | |
Title | |
Related Topics | Oncology, Experimental cancer drugs, Clusters of differentiation, Transcription factors, Proteins |
Status | Application |
Moexa Pharmaceuticals Frequently Asked Questions (FAQ)
When was Moexa Pharmaceuticals founded?
Moexa Pharmaceuticals was founded in 2014.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
